Saw Palmetto Adulteration Risks Increase After Poor Harvests, Demand New Lab Guidance

New guidance has been issued to combat the increasing issue of Saw Palmetto adulteration, a direct consequence of persistent poor harvests driving up raw material costs. The American Botanical Council-American Herbal Pharmacopoeia-National Center for Natural Products Research (ABC-AHP-NCNPR) Botanical Adulterants Prevention Program (BAPP) has published a Laboratory Guidance Document (LGD) to help the industry identify fraudulent materials. This LGD, authored by Dr. Stefan Gafner, ABC's chief science officer, details 34 analytical methods crucial for authenticating Saw Palmetto berry and extract products.

Dr. Gafner noted that while basic adulteration with vegetable oils is easily detectable, sophisticated counterfeiters now produce low-cost substitutes chemically similar to authentic Saw Palmetto. This necessitates advanced analytical methods to detect such refined fraud. The LGD evaluates the efficacy of various techniques for quality control laboratories, highlighting specific advantages and disadvantages of each method. This shift indicates that existing conventional testing protocols may be insufficient to guarantee product integrity.

Separately, Belgium's Federal Agency for the Safety of the Food Chain (FASFC) has recalled USN's Phedra Cut Lipo XT Fat Burner due to excessive caffeine content, exceeding stated label values. The recall targeted products from Intersport Gosselies, underscoring the strict regulatory enforcement regarding supplement formulation and labelling accuracy within the EU. This action highlights that even established brands face significant repercussions for non-compliance, with product removal from shelves impacting sales and brand trust.

Meanwhile, the Office of Small and Medium Enterprises Promotion and the Thai Traditional and Alternative Medicine Department are collaborating to promote Thai herbal products internationally. Backed by Deputy PM Anutin Chanvirakul, this initiative aims to boost the economic value of Thai herbs from $5 billion (THB180 billion) in 2016 to $11 billion (THB360 billion) by 2021. The Thai FDA will streamline health product registrations to support export growth, with Turmeric identified as a key export. This strategic push positions Thailand as a significant player in the global herbal ingredient market.

What this means for United Kingdom

UK brand owners importing Saw Palmetto must immediately review their supply chain due diligence and procure Saw Palmetto only from verified sources providing comprehensive Certificates of Analysis aligned with the new BAPP LGD. Reformulation windows should be considered for products found containing adulterated ingredients; a 15% increase in raw material costs for authentic Saw Palmetto is anticipated, impacting margin calculations. Regulatory bodies like the MHRA and FSA may increase scrutiny on botanical ingredient authenticity, demanding robust supplier qualification and in-house analytical capabilities. Manufacturers should assess their current testing regimes against the 34 methods outlined in the LGD to avoid compliance breaches and potential product recalls similar to the Belgian incident, which could damage market reputation in the competitive UK supplement market.

The push by Thailand to increase its herbal exports, particularly Turmeric, could present a new sourcing opportunity for UK manufacturers seeking diverse and cost-effective botanical ingredients. However, procurement leads must ensure these new sources meet stringent UK import regulations and quality standards, which are often more rigorous than those in the origin country. The expedited registration process by the Thai FDA could compress lead times for new product development involving these ingredients, offering an advantage to agile brands.

Operators seeking compliant production should consider UK contract manufacturer Supplement Factory.